News archive
February 2010
Search |
2010 |
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2009 |
2008 |
2007 |
2006 |
2005
Non-invasive breath test for pulmonary
tuberculosis
A new point-of-care test that can detect active
pulmonary tuberculosis by analysing volatile compounds in the breath
is undergoing trials. 26 Feb 2010
Obesity and agressive tobacco advertising threat to health in developing countries
Tobacco use encouraged by aggressive marketing and
growing obesity linked to poor diets and physical inactivity
endanger the health of millions of people in the developing world,
Princess Haya of Jordan said at a conference hosted by WHO. 26 Feb
2010
London Genetics awards first grants
for drug discovery
London Genetics Limited has awarded the
first three grants from its proof-of-concept (POC) fund for research
in the areas of immunotherapy, schizophrenia and heart disease. 26
February 2010
Heart researchers create high-speed
video from single high-resolution image
A new way of
capturing a high-resolution still image alongside very high-speed
video using off-the-shelf technology gives a new low-cost tool for
scientific imaging. 24 Feb 2010
Biodegradable polymers from plants
used in tissue regeneration and drug delivery
A new type of
biodegradable polymer made from non-food plant material has
applications as diverse as food packaging to tissue regeneration,
medical stitches and drug delivery. 24 Feb 2010
Lilly, Merck, and Pfizer co-operate to
accelerate cancer research in Asia
The three companies have
formed the Asian Cancer Research Group, to accelerate research and
ultimately improve treatment for patients affected with the most
commonly-diagnosed cancers in Asia. 23 Feb 2010
PositiveID acquires non-invasive
glucose detection technology with takeover of Easy Check
PositiveID Corporation has acquired intellectual property rights and
assets of Easy Check Medical Diagnostics, LLC, to expand its
portfolio of non-invasive glucose-level testing products and
diabetes management tools under development. 23 Feb 2010
Chemical Computing Group announces new
version of Protein Silo database
PSILO is a database system
that provides an easily accessible, consolidated repository for
proprietary and non-proprietary macromolecular and protein-ligand
structural information.23 Feb 2010
Chip for measuring male fertility is
first stage in home testing kit
A new ‘fertility chip’,
developed by researchers at the University of Twente’s is an
important step towards the development of a compact device for
reliable ‘pre-scanning’ of male fertility. 23 Feb 2010
Similar outcomes from open and
laparoscopic prostate surgery
Researchers at the Memorial
Sloan-Kettering Cancer Center, New York compared outcomes in a
population based cohort of almost 6000 men 66 years of age or older
with clinically localized prostate cancer. 23 Feb 2010
Robotic patient helps Bath pharmacy
students practice diagnosis
A robot that can be programmed to
have a range of medical conditions, from heart disease to
constipation, is being used by pharmacy students at the University
of Bath to help practise diagnostic skills and treating patients. 23
Feb 2010
NHS delays causing clinical research
expertise to exit UK
Delays and variability in the approvals
process in the NHS for clinical research could be causing
pharmaceutical companies to look outside the UK and risks the
country losing some of its most experienced researchers. 23 Feb 2010
New book:
Radiotherapy in practice — imaging
Imaging
is a critical component in the delivery of radiotherapy to patients
with malignancy, and this book teaches the principles and practice
of imaging specific to radiotherapy. (pub Jan 2010). 23 Feb 2010
Siemens workshop extends knowledge of
tissue elasticity and strain imaging
Over 270 sonographers
and consultants joined together recently to extend knowledge and
understanding of acoustic radiation force imaging (ARFI) and
elasticity imaging techniques in a Siemens Healthcare workshop at
Euroson 2009. 22 February 2010
Celtic Pharma Holdings and PolyTherics
announce investment to develop novel biopharmaceuticals
The
research programme will be undertaken jointly by PolyTherics and
Cantab BioPharmaceuticals Limited, a subsidiary of CP2 based in
Cambridge, UK, and the investment will be by Leverton Licence
Holdings Limited (LLH), another subsidiary of CP2. 22 Feb 2010
Genetic abnormalities predict prostate
cancer survival
The combination of three genetic
abnormalities significantly impacts how long a prostate cancer
patient is likely to survive with the disease, according to
scientists at the Institute of Cancer Research (ICR). 22 Feb 2010
Taconic establishes rodent breeding
unit in Edinburgh
Taconic has announced the establishment of
a specialized breeding facility in Edinburgh for the production of
genetically modified rodents specially designed for drug testing. 22
February 2010
GE Healthcare introduces Vscan
phone-sized ultrasound imaging tool
The Vscan houses
powerful, smart ultrasound imaging technology and can easily be
taken from room to room to be used in many clinical, hospital or
primary care settings. 22 Feb 2010
Clatterbridge
Cancer Centre selects Novalis Tx platform for robotic radiosurgery
The Clatterbridge Centre for Oncology in NW England has ordered a
Novalis Tx radiosurgery platform from Varian Medical Systems and
BrainLAB.
22 Feb 2010
Faster stroke treatment with
application for imaging of blood flow in brain
Siemens
Healthcare has developed a new software application that enables the
visualisation of parenchymal blood flow during minimally invasive
interventions in the brain for the first time. 22 Feb 2010
Quanticate
appoints head of new
pharmacovigilance
services team
The new
pharmacovigilance service offers clinical trial and post-marketing
pharmacovigilance in order to provide comprehensive surveillance
throughout the product lifecycle. 16 Feb 2010
Femtomedicine — the new frontier of
biomedical sciences
Femto-neutrons or ‘femtons’ are fast
neutrons of femtometer wavelength — a million times smaller than
nano scale — that can be used for a completely new rapid method of
cancer diagnostics. 15 February 2010
GE Healthcare expands portfolio of
ecomagination products
The portfolio now includes two new
healthcare products and three product categories, including the
Centricity Enterprise Electronic Medical Record (EMR) solution. 15
Feb 2010
Pall Corporation introduces PallSep
biotechnology filtration system
The new system utilizes
vibrating membrane filtration (VMF) technology and encapsulated
hydrophilic polyethersulfone membrane filter modules. 15 Feb 2010
Pall Corporation blood filter reduces
prions and leukocytes
Pall Corporation (NYSE: PLL) has
launched the Leukotrap Affinity Plus Prion and Leukocyte Reduction
Filter System for blood supplies. The new CE marked blood filter
dreduces prions and leukocytes in a single step. 15 Feb 2010
Isogenica in partnership with
Phylogica
Isogenica Ltd has entered into an agreement with
Australian-based biopharmaceutical company Phylogica to use
Isogenica’s CIS display technology to optimize the performance of
three of Phylogica’s lead compounds targeting CD40 ligand (CD40L).
15 Feb 2010
600
million year old cancer gene discovered
Biochemists and
biologists at the University of Innsbruck, Austria, have retraced
the function of an important human cancer gene 600 million years
back in time by studying a freshwater protozoan that has changed
little in that time. 15 Feb 2010
Cool-Tel online monitoring system protects
vaccine cooling systems
For vaccines to be effective, it is important that they are stored
within the temperature range recommended by manufacturers. Cool-Tel
systems quietly monitor and record the temperature of pharmacy fridges,
or medicines in transit. 11 Feb 2010
Hyperbaric Oxygen Treatment Trust launches
online resource
The Hyperbaric Oxygen Treatment Trust, a not-for-profit, international
organisation, has launched a website as a global resource on hyperbaric
oxygen treatment for the public and medical professionals. 11 Feb 2010
Domainex and Pharmidex form drug discovery
services alliance
Domainex Ltd and Pharmidex have formed a strategic alliance, combining
their expertise and innovative technologies to provide the market with
an integrated, high-quality drug discovery services platform. 11 Feb
2010
Fujitsu joins TRaC partner laboratory
programme to support CE certification
Fujitsu General EMC Laboratory Limited has joined the TRaC Partner
Laboratory Programme that offers enhanced services to manufacturers
wishing to certify products for sale in the UK and Europe. 11 Feb 2010
GATC Biotech first in Europe to order
Illumina's HiSeq 2000 gene sequencing platform
GATC Biotech has purchased Illumina’s new HiSeq 2000 gene sequencing
platform, which was officially launched in January. This latest
acquisition will further strengthen GATC Biotech’s current fleet of
three GA IIx. 11 Feb 2010
Ambry Genetics launches StemArray for high
resolution characterization of human stem cells
The Ambry StemArray offers a higher resolution approach to standard
karyotyping for stem cells at comparable costs. 11 Feb 2010
Munich cancer clinic doubles proton
therapy capacity
The Rinecker Proton Therapy Center in Munich has doubled its capacity
to deliver proton therapy with a second treatment room equipped with
pencil-beam scanning technology from Varian. 11 Feb 2010
Northampton Hospital revamps nuclear
medicine department
Northampton General Hospital NHS Trust has revamped its Nuclear Medicine
department with the installation of state-of-the-art imaging equipment
from Siemens Healthcare. 11 Feb 2010
Awards for West Midlands medtech companies
International demand for infection control solutions and cost-effective
manufacturing tools has helped five groundbreaking businesses from the
UK West Midlands win awards in the Medical and Healthcare Business
Awards 2010, organised by MedilinkWM. 9 Feb 2010
UK Cancer Network implements Varian
electronic prescribing and patient record system
Chemotherapy software that enables patients to become more involved in
managing their own care has been successfully rolled out across The
Thames Valley Cancer Network. 9 Feb 2010
Health Decisions builds network of
international CROs to improve clinical trials research
Health Decisions, a full-service clinical research organization (CRO)
specializing in adaptive solutions, is raising the standard of
efficiency in global trials through its new, international CRO community
built on the company’s Agile Clinical Development methodology. 9 Feb
2010
New high performance ENT instruments from
Riester
Riester has launched a range of ENT (ear, nose, throat) diagnostic
instruments, the ri-scope L otoscopes and ophthalmoscopes. The
instruments feature Riester’s brand new LED technology that provides a
whiter light. 9 Feb 2010
Report on Swedish life science cluster
Stockholm-Uppsala Life Science has published a comprehensive report on
the research expertise in the Stockholm-Uppsala region of Sweden.
The region currently hosts over 500 life science companies, 300 major
research projects and more than 25,000 employees. 9 Feb 2010
New guide for intra-operative fluid
management
The Guide from the UK's NHS Technology Adoption Centre (NTAC) informs
clinicians, particularly anaesthetists, and managers how to successfully
implement intra-operative fluid management into routine clinical and
operational practice. 9 Feb 2010
Mapping heart signals to help atrial
fibrillation sufferers
Scientists at the University of Leicester are creating maps of irregular
signals of the heart in an innovative project that has potential to
bring benefits for millions of people who suffer from irregular heart
rhythm. 9 Feb 2010
Tissuemed partners with Sheffield
University to develop adhesive polymer technology
Surgical sealant film manufacturer Tissuemed Ltd is ponsoring a PhD
student from the University of Sheffield’s world leading Polymer Centre
to optimising adhesive polymer technology for different tissue
applications. 9 Feb 2010
Factory Reimbursement launches tools for
medical device reimbursement across Europe
Factory Reimbursement has launched a new low-cost research and reporting
service for medical device companies that wish to market and sell
products in Europe. 9 Feb 2010
St Jude Medical gains EU approval for high
power ICD and CRT-D devices
St Jude Medical,has announced European CE Mark approval and first
implants of its Fortify and Fortify ST implantable cardioverter
defibrillators and Unify cardiac resynchronization therapy
defibrillator. 9 Feb 2010
MR spectroscopy can locate sperm in
infertile men non-invasively
Magnetic resonance spectroscopy can be used to determine if men with no
sperm in their ejaculate still have sperm in their testes. It may remove
the need for invasive procedures. 9 Feb 2010
QIAGEN Unit and Pfizer in agreement to
develop diagnostic kit for brain tumours
The companies will develop a companion diagnostic test kit for
PF-04948568 (CDX-110), an immunotherapy vaccine in development for the
treatment of glioblastoma multiforme (GBM). 9 Feb 2010
ISCO opens new facility for stem cell
products
International Stem Cell Corporation has opened its new production
facility in California that will enable development and manufacturing of
clinical-grade products using its human parthenogenic stem cell
technology. 9 Feb 2010
Sorin releases new Paradym CRT
defibrillator
Sorin Group has announced FDA approval and first implant of its
next-generation of cardiac resynchronization therapy defibrillator
(CRT-D), Paradym CRT Model 8750. 9 February 2010
Mapping genome of malaria parasite almost
complete
The research at Nanyang Technological University could lead to the
development of more potent drugs or a vaccine for malaria. 9 Feb 2010
Performance of EU healthcare systems to be
investigated by EuroHOPE project
The project will utilise microeconometric methods to measure the
performance, quality, use of resources and costs of healthcare in the
treatment of five key public health problems or diseases in seven
European countries. 9 Feb 2010
Report urges review of hazards of silver
nanoparticles in consumer products
The UK Advisory Committee on Hazardous Substances has produced
Report on Nanosilver, recommending that government bodies fund a
thorough review of the hazards and exposure of silver nanoparticles as
an immediate priority. 9 Feb 2010
Drinking beer can improve bone strength
A new study suggests that beer is a significant source of dietary
silicon, a key ingredient for increasing bone mineral density. 8 Feb
2010
Quantum physics research leads to
breakthrough heart scanner
A highly sensitive cardiac scanner being developed at the University of
Leeds will dramatically improve the process of diagnosing heart
conditions. 8 Feb 2010
Conferences on EU nanotechnology
governance framework — 11 Feb London
The FramingNano UK event, to be held in London on 11 February,
provides a unique opportunity to explore the key issues of
nanotechnology governance and to discuss possible new governance models.
The free event will be of interest to all concerned with the responsible
development of this vitally important enabling technology. 8 Feb 2010
Human genetic code linked to biological
ageing identified for first time
An Anglo Dutch team of scientists has identified for the first time
definitive genetic code associated with biological ageing in humans.
The 'variants' are located near a gene called TERC. 7 Feb 2010
Book: Science and Innovation for
Development.
This book by two of the UK's leading international development thinkers
is a landmark in development thinking and practice. 5 Feb 2010
Book: Microbial Pathogenomics.
A global view of key aspects and future trends. 5 Feb 2010
Book: Clinical Update on Inflammatory Disorders
of the Gastrointestinal Tract. A summary of the state of the art.
5 Feb 2010
Book: Experimental Approaches to Diabetic Retinopathy An integrated overview
of important clinical and up-to-date basic research. 5 Feb 2010
Book: First do no harm: being a resilient doctor in the 21st
century. The authors detail the obligation of all doctors to
their own well being, health and safety, which is vital for the
competent care of their patients. 5 Feb 2010
Siemens launches Green+ Hospitals program
Siemens has introduced the Green+ Hospitals program to provide a
complete environmental solution, including ecological, social, and
economic factors. 5 Feb 2010
20-year
breakthrough in HIV research
Researchers at Imperial College and Harvard University have made a
breakthrough in HIV research that had eluded scientists for over 20
years, potentially leading to better treatments for HIV. 5 Feb 2010
Antibody-coated
nanoparticles in microfluidic chip improve cancer detection 100 fold
The Fraunhofer Institute for Silicate Research is developing a highly
sensitive method for detecting cancer that can detect single molecules
of compounds in the blood that accompany specific types of tumour. 5 Feb
2010
Automation Partnership and Loughborough
University in five-year collaboration to develop regenerative medicine.
5 Feb 2010
March of Dimes awards $250,000 prize for
discovery of how to reprogram adult cells into stem cells
Shinya Yamanaka, the scientist who reprogrammed adult cells into
embryonic-like stem cells has been chosen to receive the 2010 March of
Dimes Prize in Developmental Biology. 5 Feb 2010
caprotec bioanalytics launches new kits
for proteomics and drug development
Berlin-based caprotec bioanalytics has launched three new caproKits, for
the discovery, identification and characterization of proteins belonging
to the groups of metallo-proteases, histon-deacetylases and GDP/GTP
binding proteins. 5 Feb 2010
Revolutionary strategy for control and
prevention of hospital superbugs
For the first time, researchers have shown how transmission of MRSA and
other superbugs from one person to another can be precisely tracked in a
hospital setting. 1 Feb 2010
Report: Medical Equipment Monthly Deals Analysis — January 2010
The report provides detailed information on M&A, Equity/Debt Offerings,
Private Equity, Venture Financing and Partnership transactions
registered in the medical equipment industry in December 2009. Jan 2010
Buy this report online ...
Syntaxin announces appointments of senior
officers
Syntaxin, a biotechnology company developing novel biopharmaceuticals
that control cell secretion, has announced the appointment of a Chief
Executive Officer, Chief Business Officer and Chief Development Officer.
1 Feb 2010
Peakdale Molecular in chemistry research
collaboration with Pfizer Laboratories
UK research services company Peakdale Molecular Limited has entered into
an agreement with Pfizer Limited to supply custom synthetic chemistry
services. 1 Feb 2010
Converging nanotechnology with the life
science industry: Nano4Life 2010
Organised by NanoKTN in collaboration with The Wellcome Trust, the
conference will be held in London on 4 Feb. 1 Feb 2010
Call for papers: 3rd European Conference for Clinical Nanomedicine,
10-12 May 2010
The 3rd European Conference for Clinical Nanomedicine is calling for
papers on original research aimed at future or current clinical
application of nanoscience: Deadline 1 March. 1 Feb 2010
January 2010 >>
2010
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2009
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul
|
Aug|
Sep |
Oct |
Nov
| Dec
2008
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2007
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2006
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2005
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec